Reduction of maximal oxygen uptake in sarcoidosis: Relationship with disease severity

Respiration

Volumn 82, Issue 6, 2011, Pages 501-508

  Wallaert, Benoit ^a,c   Talleu, Christelle ^a   Wemeau Stervinou, Lidwine ^a   Duhamel, Alain ^b   Robin, Sophie ^c   Aguilaniu, Bernard ^d  

^a Clinique des Maladies Respiratoires   (France)

^b Unité de Biostatistiques   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d HYLAB   (France)

Author keywords

Cardiopulmonary exercise testing; Dyspnea; Exercise; Pulmonary function; Sarcoidosis

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE SEVERITY; DYSPNEA; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTIONAL ASSESSMENT; HEART RATE; HUMAN; LUNG FUNCTION TEST; LUNG GAS EXCHANGE; LUNG HILUS; LUNG SARCOIDOSIS; LUNG VENTILATION; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; TOTAL LUNG CAPACITY; TREATMENT PLANNING;

ADULT; AGED; ANAEROBIC THRESHOLD; DYSPNEA; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; OXYGEN; PREDICTIVE VALUE OF TESTS; PULMONARY GAS EXCHANGE; REST; RETROSPECTIVE STUDIES; SARCOIDOSIS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 82255196094     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000330050     Document Type: Article

References (41)

1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-755.
2. Matthews JI, Hooper RG: Exercise testing in pulmonary sarcoidosis. Chest 1983; 83: 75-81. (Pubitemid 13172754)
3. Brancaleone P, Perez T, Robin S, Neviere R, Wallaert B: Clinical impact of inspiratory muscle impairment in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 219-227. (Pubitemid 39472247)
4. Marcellis RG, Lenssen AF, Elfferich MD, et al: Exercise capacity, muscle strength and fatigue in sarcoidosis. Eur Respir J 2011.
5. Delobbe A, Perrault H, Maitre J, et al: Impaired exercise response in sarcoid patients with normal pulmonary functio. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 148-153. (Pubitemid 34685915)
6. Kollert F, Geck B, Suchy R, et al: The impact of gas exchange measurement during exercise in pulmonary sarcoidosis. Respir Med 2011; 105: 122-129.
7. Miller TD, Staats BA: Impaired exercise tolerance after inferior vena caval interruption. Chest 1988; 93: 776-780. (Pubitemid 18097419)
8. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003; 167: 211-277.
9. Jones NL: Clinical Exercise Testing, ed 4. Philadelphia, WB Saunders, 1997.
10. Ferrazza AM, Martolini D, Valli G, Palange P: Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases. Respiration 2009; 77: 3-17.
11. Kent DC, Spence W: Physiologic abnormalities in pulmonary sarcoidosis. Dis Chest 1964; 46: 680-691.
12. Ingram CG, Reid PC, Johnston RN: Exercise testing in pulmonary sarcoidosis. Thorax 1982; 37: 129-132. (Pubitemid 12135590)
13. Miller A, Brown LK, Sloane MF, Bhuptani A, Teirstein AS: Cardiorespiratory responses to incremental exercise in sarcoidosis patients with normal spirometry. Chest 1995; 107: 323-329.
14. Karetzky M, McDonough M: Exercise and resting pulmonary function in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1996; 13: 43-49. (Pubitemid 26162217)
15. Akkoca O, Celik G, Ulger F, et al: Exercise capacity in sarcoidosis. Study of 29 patients. Med Clin (Barc) 2005; 124: 686-689.
16. Wanger J, Clausen JL, Coates A, et al: Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26: 511-22. (Pubitemid 41264217)
17. Macintyre N, Crapo RO, Viegi G, et al: Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26: 720-735. (Pubitemid 41448672)
18. Aguilaniu B, Richard R, Costes F, et al: Méthodologie et Pratique de l'Exploration Fonctionnelle á l'Exercice (EFX). Rev Mal Respir 2007; 24: 2S111-2S160. (Pubitemid 46548082)
19. Hansen JE, Sue DY, Wasserman K: Predicted values for clinical exercise testing. Am Rev Respir Dis 1984; 129:S49-S55. (Pubitemid 14190983)
20. Hansen JE, Wasserman K: Pathophysiology of activity limitation in patients with interstitial lung disease. Chest 1996; 109: 1566-1576. (Pubitemid 26193386)
21. Sauerbrei W, Schumacher M: A bootstrap resampling procedure for model building: Application to the Cox regression model. Stat Med 1992; 11: 2093-2109. (Pubitemid 23066842)
22. Sietsema KE, Kraft M, Ginzton L, Sharma OP: Abnormal oxygen uptake responses to exercise in patients with mild pulmonary sarcoidosis. Chest 1992; 102: 838-845.
23. Spiro S, Dowdeswell I, Clark T: An analysis of submaximal exercise responses in patients with sarcoidosis and fibrosing alveolitis. Br J Dis Chest 1981; 75: 169-180. (Pubitemid 11096849)
24. Medinger AE, Khouri S, Rohatgi PK: Sarcoidosis: The value of exercise testing. Chest 2001; 120: 93-101. (Pubitemid 32744863)
25. Athos L, Mohler JG, Sharma OP: Exercise testing in the physiologic assessment of sarcoidosis. Ann NY Acad Sci 1986; 465: 491-501. (Pubitemid 16006589)
26. Barros WG, Neder JA, Pereira CA, Nery LE: Clinical, radiographic and functional predictors of pulmonary gas exchange impairment at moderate exercise in patients with sarcoidosis. Respiration 2004; 71: 367-373. (Pubitemid 39179172)
27. Wasserman K, Hansen JE, Sue DY, Casaburi R, Whipp BJ: Principles of exercise testing and interpretation. Fourth Edition 2005.
28. Gibbons WJ, Levy RD, Nava S, et al: Subclinical cardiac dysfunction in sarcoidosis. Chest 1991; 100: 44-50.
29. Sharma OP, Maheshwari A, Thaker K: Myocardial sarcoidosis. Chest 1993; 103: 253-258. (Pubitemid 23027268)
30. Roberts WC, McAllister HA, Jr, Ferrans VJ: Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 1977; 63: 86-108. (Pubitemid 8146656)
31. Ellestad MH: Chronotropic incompetence. The implications of heart rate response to exercise (compensatory parasympathetic hyperactivity?). Circulation 1996; 93: 1485-1487.
32. Okayama K, Kurata C, Tawarahara K, Wakabayashi Y, Chida K, Sato A: Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest 1995; 107: 330-334.
33. Tellier P, Paycha F, Antony I, et al: Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis. Am J Med 1988; 85: 189-193.
34. Wasserman K, Hansen JE, Sue DY, Casaburi R, Whipp BJ: Principles of exercise testing and interpretation, ed 3. Philadelphia, Lippincott Williams and Wilkins, 1999.
35. Stringer WW, Hansen JE, Wasserman K: Cardiac output estimated noninvasively from oxygen uptake during exercise. J Appl Physiol 1997; 82: 908-912. (Pubitemid 27123273)
36. Michielsen HJ, Drent M, Peros-Golubicic T, De Vries J: Fatigue is associated with quality of life in sarcoidosis patients. Chest 2006; 130: 989-994. (Pubitemid 44583726)
37. Leroy S, Just N, Zanetti C, et al: The role of exercise testing in the management of systemic sarcoidosis. Rev Mal Respir 2003; 20: 777-781. (Pubitemid 37429427)
38. Morawiec E, Hachulla-Lemaire AL, Chabrol J, Remy-Jardin M, Wallaert B: Venoatrial compression by lymphadenopathy in sarcoidosis. Eur Respir J 2010; 35: 1188-1191.
39. Peronnet F, Aguilaniu B: Lactic acid buffering, nonmetabolic CO2 and exercise hyperventilation: A critical reappraisal. Respir Physiol Neurobiol 2006; 150: 4-18. (Pubitemid 43156394)
40. Dempsey JA: Challenges for future research in exercise physiology as applied to the respiratory system. Exerc Sport Sci Rev 2006; 34: 92-98. (Pubitemid 44620165)
41. Baughman RP, Engel PJ, Meyer CA, Barrett AB, Lower EE: Pulmonary hypertension in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006; 23: 108-116. (Pubitemid 47471829)